Abbott reports cyberattack on cancer diagnostics business

As reported by MedTech Dive, Abbott disclosed on Thursday that a cyberattack has impacted its cancer diagnostics business, leading to unauthorized access to a limited number of internal systems.

The medical device company stated that the breach did not affect other Abbott businesses, sites, or systems. The affected cancer diagnostics business includes Exact Sciences, which Abbott acquired earlier this year. Abbott emphasized that the incident has no impact on business operations, product availability, manufacturing, or patient care, and does not expect a material financial impact. Following the discovery, Abbott engaged third-party cybersecurity experts and law enforcement, and an investigation is ongoing.

The company has not disclosed the specific type of information accessed or when the attack was discovered. This incident follows similar cyberattacks reported by other medtech companies, including Stryker, Intuitive, Medtronic, iRhythm, and AdaptHealth in recent months, highlighting ongoing cybersecurity challenges within the industry.

Source: MedTech Dive